Acetylsalicylic Acid (Aspirin, BAYE4465) + Pseudoephedrine + Placebo

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Common Cold

Conditions

Common Cold

Trial Timeline

Sep 1, 2009 → Mar 1, 2012

NCT ID

NCT00963443

About Acetylsalicylic Acid (Aspirin, BAYE4465) + Pseudoephedrine + Placebo

Acetylsalicylic Acid (Aspirin, BAYE4465) + Pseudoephedrine + Placebo is a phase 3 stage product being developed by Bayer for Common Cold. The current trial status is completed. This product is registered under clinical trial identifier NCT00963443. Target conditions include Common Cold.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00963443	Phase 3	Completed	Sep 1, 2009	Mar 1, 2012	Common Cold

Competing Products

20 competing products in Common Cold

See all competitors

Product	Company	Stage	Hype Score
Nasal Glucagon + Oxymetazoline	Eli Lilly	Phase 1	33
New Formulation Phenylephrine HCl + Marketed Phenylephrine HCl + Placebo	Johnson & Johnson	Phase 2	52
Pseudoephedrine/Paracetamol	Johnson & Johnson	Approved	85
Zostavax®	Merck	Pre-clinical	23
Lidocaine 8mg + CPC 2mg + Lidocaine 1mg + CPC 2mg	Novartis	Phase 3	77
CDZ173	Novartis	Phase 2/3	65
Dextromethorphan + Placebo	Novartis	Approved	85
Xylometazoline	Novartis	Phase 3	77
N-acetylcysteine + Placebo	Novartis	Phase 2	52
Advil Congestion Relief + Advil Allergy and Congestion Relief + Paracetamol	Pfizer	Phase 3	76
pseudoephedrine hydrochloride 30 mg tablets + Placebo tablets	Pfizer	Phase 3	76
gammaglobulin	CSL	Pre-clinical	22
Human Normal Immunoglobulin for Subcutaneous Administration (IGSC)	CSL	Phase 3	76
Vivaglobin	CSL	Approved	84
Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + Placebo	Bayer	Approved	82
Aspirin (Acetylsalicylic acid, BAYE4465) + Placebo	Bayer	Approved	82
Acetylsalicylic acid (Aspirin, BAYE4465) & Lidocain + Acetylsalicylic Acid (Aspirin, BAYE4465) + Lidocain + Placebo	Bayer	Phase 3	74
Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine + Acetylsalicylic Acid (Aspirin, BAYE4465) + Pseudoephedrine + Placebo	Bayer	Phase 3	74
Acetylcysteine + Paracetamol + Phenylephrine	Sandoz Group	Phase 3	74
A-101	Aclaris Therapeutics	Phase 3	69

Other Products from Bayer

TelmisartanApproved

Clotrimazole vaginal tablet + FluconazoleApproved

Levitra (Vardenafil, BAY38-9456)Approved

Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved

Rivaroxaban 20 MG + WarfarinApproved